Patents by Inventor James E. Trosko

James E. Trosko has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7195789
    Abstract: A composition comprising a non-fiber organic extract of psyllium which is anti-tumorigenic is described. The composition both restores gap junctional intercellular communication (GJIC) and inhibits anchorage independent growth of mammalian cells which have been transformed with the ras oncogene. The composition is a useful chemotherapy and chemopreventative agent. The composition was identified using a novel method for determining the anti-tumorigenic potential of a compound or composition.
    Type: Grant
    Filed: February 27, 2003
    Date of Patent: March 27, 2007
    Assignee: Board of Trustees of Michigan State University
    Inventors: Yasushi Nakamura, Brad L. Upham, James E. Trosko
  • Publication number: 20030180400
    Abstract: A composition comprising a non-fiber organic extract of psyllium which is anti-tumorigenic is described. The composition both restores gap junctional intercellular communication (GJIC) and inhibits anchorage independent growth of mammalian cells which have been transformed with the ras oncogene. The composition is a useful chemotherapy and chemopreventative agent. The composition was identified using a novel method for determining the anti-tumorigenic potential of a compound or composition.
    Type: Application
    Filed: February 27, 2003
    Publication date: September 25, 2003
    Applicant: Board of Trustees of MICHIGAN STATE UNIVERSITY
    Inventors: Yasushi Nakamura, Brad L. Upham, James E. Trosko
  • Publication number: 20030003088
    Abstract: A human pancreatic ductal epithelial cell line immortalized with the human papilloma virus E6 and E7 genes which has stem cell-like characteristics and which can be induced to differentiate into ductal-like cells and beta-like cells that produce insulin. The immortal cells or derivative thereof are useful for treating insulin-dependent diabetes and in assays for determining the ability of a chemical to induce pancreatic stem cell differentiation or malignancy.
    Type: Application
    Filed: April 30, 2002
    Publication date: January 2, 2003
    Applicant: Board of Trustees operating Michigan State University
    Inventors: Ming Sound Tsao, James E. Trosko, Burra V. Madhukar, Lawrence K. Olson, Loretta VanCamp
  • Patent number: 5814511
    Abstract: Described is a substantially purified human breast epithelial cell (Type I HBEC) displaying the following characteristics: variable cell shape; smooth cell colony boundary; deficiency in gap junctional intercellular communication; positive expression of epithelial membrane antigen and keratin 18; negative expression of keratin 14, .alpha.6 integrin and gap junction genes for connexins (Cx26, Cx32 and Cx43); growth promotion by fetal bovine serum; induction by cholera toxin to differentiate into Type II HBEC (prior art); and acquisition anchorage independent growth by Semian virus 40 transfection. Also described is a method of obtaining the above-identified epithelial cells comprising the steps of: a) development of a mixture of human breast epithelial cells from reduction mammoplasty tissues using the MSU-1 medium; b) eliminating stromal fibroblasts by a trypsin (0.002%) and ethylenediamine tetraacetic acid (0.
    Type: Grant
    Filed: November 16, 1995
    Date of Patent: September 29, 1998
    Assignee: Michigan State University
    Inventors: Chia-Cheng Chang, James E. Trosko
  • Patent number: 5650317
    Abstract: Described is a substantially purified human breast epithelial cell (Type I HBEC) displaying the following characteristics: variable cell shape; smooth cell colony boundary; deficiency in gap junctional intercellular communication; positive expression of epithelial membrane antigen and keratin 18; negative expression of keratin 14, .alpha.6 integrin and gap junction genes for connexins (Cx26, Cx32 and Cx43); growth promotion by fetal bovine serum; induction by cholera toxin to differentiate into Type II HBEC (prior art); and acquisition of anchorage independent growth by Semian virus 40 transfection. Also described is a method of obtaining the above-identified epithelial cells comprising the steps of: a) development of a mixture of human breast epithelial cells from reduction mammoplasty tissues using the MSU-1 medium; b) eliminating stromal fibroblasts by a trypsin (0.002%) and ethylenediamine tetraacetic acid (0.
    Type: Grant
    Filed: September 16, 1994
    Date of Patent: July 22, 1997
    Assignee: Michigan State University
    Inventors: Chia-Cheng Chang, James E. Trosko